These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8097165)

  • 21. The effects of umespirone as a potential anxiolytic and antipsychotic agent.
    Barnes NM; Costall B; Domeney AM; Gerrard PA; Kelly ME; Krähling H; Naylor RJ; Tomkins DM; Williams TJ
    Pharmacol Biochem Behav; 1991 Sep; 40(1):89-96. PubMed ID: 1685786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anxiolytic effects of CCK-B antagonists.
    Costall B; Domeney AM; Hughes J; Kelly ME; Naylor RJ; Woodruff GN
    Neuropeptides; 1991 Jul; 19 Suppl():65-73. PubMed ID: 1679211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5-HT release in the frontal cortex of freely-moving rats.
    Cheng CH; Costall B; Ge J; Naylor RJ
    Br J Pharmacol; 1993 Nov; 110(3):1079-84. PubMed ID: 7507776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analgesic effects of S and R isomers of the novel 5-HT3 receptor antagonists ADR-851 and ADR-882 in rats.
    Sufka KJ; Giordano J
    Eur J Pharmacol; 1991 Oct; 204(1):117-9. PubMed ID: 1804661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride.
    Barnes NM; Cheng CH; Costall B; Ge J; Naylor RJ
    Br J Pharmacol; 1992 Sep; 107(1):233-9. PubMed ID: 1384906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The anxiolytic-like activity of GR159897, a non-peptide NK2 receptor antagonist, in rodent and primate models of anxiety.
    Walsh DM; Stratton SC; Harvey FJ; Beresford IJ; Hagan RM
    Psychopharmacology (Berl); 1995 Sep; 121(2):186-91. PubMed ID: 8545524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are there changes in sensitivity to 5-HT3 receptor ligands following chronic diazepam treatment?
    Andrews N; File SE
    Psychopharmacology (Berl); 1992; 108(3):333-7. PubMed ID: 1523283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The identification of heterogeneity of 5-HT3 receptors with [3H]RS-42358-197.
    Wong EH; Bonhaus DW; Eglen RM
    Adv Exp Med Biol; 1995; 363():97-108. PubMed ID: 7618534
    [No Abstract]   [Full Text] [Related]  

  • 29. Antagonists at the serotonin-3 receptor can reduce the fear-potentiated startle response in the rat: evidence for different types of anxiolytic activity?
    Nevins ME; Anthony EW
    J Pharmacol Exp Ther; 1994 Jan; 268(1):248-54. PubMed ID: 7905528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antianxiety profile of ondansetron, a selective 5-HT3 antagonist, in a novel animal model.
    Roychoudhury M; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1997 Mar; 19(2):107-11. PubMed ID: 9151286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects on general behaviour and neurotransmitter functions of a new 5-hydroxytryptamine3 receptor antagonist with potential therapeutic relevance in central nervous system disturbances.
    Rizzi CA; Prudentino A; Giraldo E
    Arzneimittelforschung; 1993 Oct; 43(10):1033-41. PubMed ID: 7903536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of ketotifen in rodent models of anxiety and on the behavioural consequences of withdrawing from treatment with drugs of abuse.
    Costall B; Kelly ME; Onaivi ES; Naylor RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Jun; 341(6):547-51. PubMed ID: 2392157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anxiolytic-like activity of R(+)- and S(-)-zacopride in mice.
    Young R; Johnson DN
    Eur J Pharmacol; 1991 Aug; 201(2-3):151-5. PubMed ID: 1686755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The psychopharmacology of 5-HT3 receptors.
    Costall B; Naylor RJ; Tyers MB
    Pharmacol Ther; 1990; 47(2):181-202. PubMed ID: 2203069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LY277359 maleate: a potent and selective 5-HT3 receptor antagonist without gastroprokinetic activity.
    Cohen ML; Bloomquist W; Gidda JS; Lacefield W
    J Pharmacol Exp Ther; 1990 Jul; 254(1):350-5. PubMed ID: 2366187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of DAU 6215, a novel 5-hydroxytryptamine3 (5-HT3) antagonist on electrophysiological properties of the rat hippocampus.
    Passani MB; Pugliese AM; Azzurrini M; Corradetti R
    Br J Pharmacol; 1994 Jun; 112(2):695-703. PubMed ID: 8075890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam.
    Costall B; Jones BJ; Kelly ME; Naylor RJ; Oakley NR; Onaivi ES; Tyers MB
    Pharmacol Biochem Behav; 1989 Dec; 34(4):769-78. PubMed ID: 2576143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strain-dependent effects of diazepam and the 5-HT2B/2C receptor antagonist SB 206553 in spontaneously hypertensive and Lewis rats tested in the elevated plus-maze.
    Takahashi RN; Berton O; Mormède P; Chaouloff F
    Braz J Med Biol Res; 2001 May; 34(5):675-82. PubMed ID: 11323756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anxiolytic-like effect of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (60) in experimental mouse models of anxiety.
    Bhatt S; Mahesh R; Devadoss T; Jindal A
    Indian J Exp Biol; 2013 Jul; 51(7):510-4. PubMed ID: 23898549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models.
    Gupta D; Radhakrishnan M; Thangaraj D; Kurhe Y
    Eur J Pharmacol; 2014 Jul; 735():59-67. PubMed ID: 24747753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.